Aberdeen Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Aberdeen Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-43,738	Closed	-$165K	–	958
2025 Q3	$165K	Sell	43,738 -92,733	-68%	-$315K	﹤0.01%	947
2025 Q2	$330K	Sell	136,471 -26,109	-16%	-$35.4K	﹤0.01%	914
2025 Q1	$134K	Hold	162,580	–	–	﹤0.01%	934
2024 Q4	$138K	Hold	162,580	–	–	﹤0.01%	925
2024 Q3	$202K	Hold	162,580	–	–	﹤0.01%	903
2024 Q2	$272K	Hold	162,580	–	–	﹤0.01%	903
2024 Q1	$302K	Hold	162,580	–	–	﹤0.01%	903
2023 Q4	$309K	Buy	+162,580	New	+$243K	﹤0.01%	909
2022 Q1	–	Sell	-4,381	Closed	-$208K	–	1013
2021 Q4	$208K	Sell	4,381 -105	-2%	-$6.3K	﹤0.01%	1036
2021 Q3	$325K	Sell	4,486 -202	-4%	-$14.6K	﹤0.01%	1001
2021 Q2	$394K	Buy	+4,688	New	+$309K	﹤0.01%	954

Other funds holding NBP

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ACM

Ariose Capital Management Central, Hong Kong, Hong Kong $84.3M AUM 538.03% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Aberdeen Group's NBP Position: Q4 2025 in Review

Aberdeen Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2025, closing a stake of 43,738 shares — an estimated $165K sold.

Aberdeen Group first reported a position in NBP in Q2 2021 and held it in 11 quarters. The position peaked at $394K in Q2 2021. 57 funds tracked by Wall St. Rank hold NBP as of Q4 2025.

Aberdeen Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2025 after selling out during the quarter.
Aberdeen Group sold 43,738 NovaBridge Biosciences American Depositary Shares shares in Q4 2025, an estimated $165K.
Aberdeen Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 11 quarters.
Aberdeen Group's NovaBridge Biosciences American Depositary Shares position peaked at $394K in Q2 2021.
57 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2025.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.